Naloxon B. Braun (Naloxone Hydrochloride)

Naloxone works by competitively binding to mu‑opioid receptors in the central nervous system, displacing opioid molecules and blocking their activity. This antagonism stops the opioid‑induced suppression of respiratory drive and consciousness, allowing normal neuronal function and breathing to resume quickly.

The specific dose of Naloxon B. Braun is determined by the prescribing clinician based on the patient’s condition, the type of opioid involved, and the route of administration. Healthcare professionals follow established clinical guidelines and adjust the dose as needed to achieve effective reversal while minimizing withdrawal symptoms.

Safety data for naloxone in pregnancy and lactation are limited. Naloxone is generally considered low risk because it does not cross the placenta in significant amounts, but the decision to use it should be made by a qualified healthcare provider weighing the benefits of reversing a life‑threatening overdose against any potential risks.

To order Naloxon B. Braun, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required), and necessary import documentation.

Naloxon B. Braun contains naloxone, a short‑acting opioid antagonist that works rapidly and is widely used for emergency overdose reversal. Compared with longer‑acting agents such as nalmefene or naloxegol, naloxone has a quicker onset but may require repeated dosing because of its shorter duration of action.

Naloxon B. Braun should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Avoid freezing the product and keep it out of reach of children. Inspect the vial for particulate matter before use.

Naloxon B. Braun is administered by a trained healthcare professional via intramuscular or intravenous injection. The route is chosen based on the clinical situation, with intravenous injection providing the fastest onset. Proper aseptic technique and dosage calculation are essential for safe administration.

The most serious risks include severe cardiovascular events such as arrhythmia, hypertension, and pulmonary edema, as well as acute opioid withdrawal syndrome, which can be life‑threatening in patients with high opioid dependence. Anaphylactic reactions, although rare, also require immediate medical attention.

Naloxon B. Braun should be avoided in individuals with a known hypersensitivity to naloxone or any component of the formulation. Caution is advised in patients with severe cardiovascular disease, as rapid reversal of opioid effects can precipitate hemodynamic instability.